Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Recommendation of "Hold" by Brokerages

Shares of Definitive Healthcare Corp. (NASDAQ:DH - Get Free Report) have been assigned a consensus recommendation of "Hold" from the twelve research firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $5.72.

A number of research firms have weighed in on DH. Stephens initiated coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They set an "equal weight" rating and a $5.00 price objective on the stock. BTIG Research began coverage on shares of Definitive Healthcare in a research note on Tuesday, September 17th. They issued a "buy" rating and a $7.00 price objective for the company. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Definitive Healthcare in a research report on Friday, November 8th.

Insider Buying and Selling at Definitive Healthcare

In other Definitive Healthcare news, insider William Moschella sold 45,000 shares of Definitive Healthcare stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the sale, the insider now directly owns 433,830 shares of the company's stock, valued at approximately $2,039,001. The trade was a 9.40 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 14.84% of the company's stock.

Hedge Funds Weigh In On Definitive Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Point72 DIFC Ltd lifted its stake in shares of Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company's stock valued at $42,000 after purchasing an additional 8,215 shares in the last quarter. Intech Investment Management LLC acquired a new stake in shares of Definitive Healthcare in the third quarter worth $55,000. Bleakley Financial Group LLC purchased a new position in shares of Definitive Healthcare in the 3rd quarter valued at $74,000. Glenmede Trust Co. NA lifted its holdings in shares of Definitive Healthcare by 41.1% during the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company's stock valued at $82,000 after acquiring an additional 5,362 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new stake in Definitive Healthcare during the 3rd quarter worth $84,000. Institutional investors and hedge funds own 98.67% of the company's stock.

Definitive Healthcare Stock Down 0.5 %

NASDAQ:DH traded down $0.02 during mid-day trading on Friday, hitting $4.23. The stock had a trading volume of 428,518 shares, compared to its average volume of 713,971. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare has a twelve month low of $3.19 and a twelve month high of $10.62. The company has a market capitalization of $488.66 million, a PE ratio of -1.36, a PEG ratio of 3.29 and a beta of 1.40. The stock has a 50-day simple moving average of $4.38 and a two-hundred day simple moving average of $4.62.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.